You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 146 No. 1, January 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Severe insulin resistance and diabetes mellitus in mandibuloacral dysplasia

G. R. Freidenberg, D. L. Cutler, M. C. Jones, B. Hall, R. J. Mier, F. Culler, K. L. Jones, C. Lozzio and S. Kaufmann
Department of Pediatrics, University of California, San Diego.

Mandibuloacral dysplasia (MAD) is a syndrome with onset in midchildhood. The predominant characteristics of MAD include flexion contractures; mandibular hypoplasia; loss of body fat; atrophic, speckled skin; and progressive osteolysis of the clavicles. We studied three males with MAD. Each had lipodystrophy of the extremities, with sparing of the face and neck. All had moderate hyperlipidemia. In response to oral glucose, each had a diabetic response, with peak insulin levels between 2870 and 22,960 pmol/L. Insulin-stimulated glucose disposal was determined in two patients with MAD. At an insulin infusion rate of 120 mU/m2 per minute, glucose disposal was less than 25% of that measured at similar levels of insulinemia in nondiabetic control subjects, indicating marked insulin resistance in patients with MAD. The insulin resistance occurred without obesity, excessive levels of counterregulatory hormones, or anti-insulin-receptor antibodies. We suggest that MAD is a previously undescribed form of lipodystrophic insulin-resistant diabetes mellitus.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Compound Heterozygosity for Mutations in LMNA in a Patient with a Myopathic and Lipodystrophic Mandibuloacral Dysplasia Type A Phenotype
Lombardi et al.
J. Clin. Endocrinol. Metab. 2007;92:4467-4471.
ABSTRACT | FULL TEXT  

Nuclear lamins: laminopathies and their role in premature ageing.
Broers et al.
Physiol. Rev. 2006;86:967-1008.
ABSTRACT | FULL TEXT  

Alterations of nuclear envelope and chromatin organization in mandibuloacral dysplasia, a rare form of laminopathy
Filesi et al.
Physiol. Genomics 2005;23:150-158.
ABSTRACT | FULL TEXT  

A Novel Homozygous Ala529Val LMNA Mutation in Turkish Patients with Mandibuloacral Dysplasia
Garg et al.
J. Clin. Endocrinol. Metab. 2005;90:5259-5264.
ABSTRACT | FULL TEXT  

Mandibuloacral dysplasia caused by homozygosity for the R527H mutation in lamin A/C
Shen et al.
J. Med. Genet. 2003;40:854-857.
FULL TEXT  

Genetic and Phenotypic Heterogeneity in Patients with Mandibuloacral Dysplasia-Associated Lipodystrophy
Simha et al.
J. Clin. Endocrinol. Metab. 2003;88:2821-2824.
ABSTRACT | FULL TEXT  

Body Fat Distribution and Metabolic Derangements in Patients with Familial Partial Lipodystrophy Associated with Mandibuloacral Dysplasia
Simha and Garg
J. Clin. Endocrinol. Metab. 2002;87:776-785.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.